VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Biotechnology industry including recent transactions, market multiples, company performance and purchase price allocation percentages.

Industry Highlights

• The second-quarter of 2022 in biotechnology / biopharma M&A activity showed a respectable $25b in committed capital. The quarter was dominated by full company takeovers, unlike quarter one where majority stake purchases and business unit buys were more common.
• On April 25, 2022 Amgen, the world’s largest biotechnology company, and Mustafa Nevzat Pharmaceuticals (MN) today announced an agreement under which Amgen will acquire 95.6 percent of shares in MN, a privately held Turkish pharmaceutical company, for an amount that values MN at US $700 million.

Past Industry Updates

Biotechnology: April 2022

Biotechnology: February 2022

Biotechnology: October 2021

Biotechnology: July 2021

Biotechnology: May 2021

Biotechnology: January 2021

Biotechnology: October 2020

Biotechnology: July 2020

Biotechnology: May 2020

Biotechnology: December 2019

Biotechnology: October 2019